Table 2.
Tissue/Organ | Action | Reference | |
---|---|---|---|
Skin | Keratinocytes |
Increased proliferation Decreased ROS following UVA exposure |
[64] |
Fibroblasts |
Decreased collagen types I, III, and V Decreased TGF-β Increased superoxide dismutase and hemoxygenase I Reduced ICAM-1 |
[61, 67] | |
Melanocytes |
Pigmentation Increased proliferation Decreased apoptosis |
[61, 66] | |
Dendritic cells | Induce tolerogenic dendritic cells | [44] | |
Kidney | Podocytes | Reduced foot process effacement | [68] |
Tubular epithelial cells | Reduced apoptosis | [14] | |
Kidney | Reduced glomerular damage in AKI model | [14] | |
CNS | Glia |
Reduced apoptosis Decreased cyclooxygenase Decreased iNOS |
[39, 53, 69–71] |
Neurons | Indirect survival | [69] | |
Cardiovascular | Endothelial cells |
Downregulation of ICAM-1, VCAM-1, and E-selectin Increased eNOS expression Increased relaxation Increased mitochondrial superoxide dismutase |
[48, 50] |
Serum lipids |
Decreased serum triglycerides and LDL cholesterol Increased HDL cholesterol |
[72–75] |